SEC Form 4 · accession 0001258394-26-000018
Guardant Health, Inc. · GH
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Roberto Mignone
Director
Period of report
Sep 21, 2026
Accepted (ET)
Sep 22, 2026 · 4:33 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001576280
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Sep 21, 2026 | M | 264 | $0.00 | A | 10,274 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Restricted Stock UnitsF1,F2 | $0.00 | Sep 21, 2026 | M | 264 | D | — | — | Common Stock | 264 | 6,600 | D |
Explanation of responses
- F1The restricted stock unit award granted on November 8, 2024 vests over a four-year period. 25% of the shares subject to such award vested on October 21, 2025 and the remaining 75% vests monthly for the three-year period thereafter.
- F2Not applicable for Restricted Stock Units.